Forbes reports the WHO sees possible safety risks for growing bodies, even as adolescent GLP-1 prescriptions have risen nearly 600%.
Recap by typeshit. Full story at Forbes on MSN.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
A preprint using health records found BPC-157 users rose from about 54 in early 2022 to 1,018 in early 2026, and most waited two months to tell a doctor.
Britain's Advertising Standards Authority has ruled against Pharmacy Online over promotions for the Wegovy pill. A regulatory step on how weight loss drugs get marketed.
Loading…